About PULMONX CORPORATION
Pulmonx is a medical technology company focused on developing and providing bronchoscopic treatments for patients with severe COPD/emphysema, specifically through the Zephyr Valve. The company emphasizes clinical evidence and patient outcomes in its approach.
Development of bronchoscopic treatments for severe COPD/emphysemaClinical trials and evidence-based treatment outcomesPatient selection and treatment protocols
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Veterans Affairs | $34K | |
| PULMONARY BRONCH VALVE STOCK | Department of Veterans Affairs | $25K | |
| Federal contract award | Department of Veterans Affairs | $90K | |
| Federal contract award | Department of Veterans Affairs | $30K | |
| Federal contract award | Department of Veterans Affairs | $41K |
Is this your company?
Claim PULMONX CORPORATION to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim PULMONX CORPORATION & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.